Epanova® for Lowering Very High Triglycerides II (EVOLVE II)

NCT02009865 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
379
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca